Excedrin Migraine
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Mild-to-moderate migraine
General Information
Bristol-Myers Squibb received approval of its Excedrin Migraine
for the treatment of pain associated with mild-to-moderate
migraine. It is the first over the counter drug to be approved for
this indication.
Clinical Results
In trials involving about 1300 migraineurs, Excedrin Migraine
was found safe and effective in relieving migraine pain within
2-to-4 hours of dosing.
Mechanism of Action
Excedrin Migraine contains 250 mg acetaminophen, 250 mg aspirin,
and 65 mg caffeine in each tablet. The ingredients are the same as
those in Excedrin Extra, which is already on the market, but the
product comes with instructions and warnings specific to
migraine.
